Skip to main content
    A

    Armata Pharmaceuticals Inc (ARMP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $2.99
    -0.88 (-22.74%)

    Market Cap: $143.94M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Armata Pharmaceuticals Inc (ARMP) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Armata Pharmaceuticals (ARMP) to earn -$1.87 per share in the fiscal year ending Dec 31, 2026, on revenue of $4.25M. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$1.45.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates fall 35.3%.

    Fiscal year ending Dec 31, 2026
    -$1.87
    EPS consensus, revenue $4.25M
    Fiscal year ending Dec 31, 2027
    -$1.45
    EPS consensus, revenue $2.75M
    Next report
    Mar 17, 2027
    Estimated

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$1.87-$2.27 to -$1.462$4.25M$3.30M to $5.20M2
    Dec 31, 2027-$1.45-$2.04 to -$0.852$2.75MN/A2

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.41-$0.56 to -$0.244$525300N/A4

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 2 upward and 2 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202620
    Fiscal year ending Dec 31, 202702

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$3.81.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$1.87-$1.87-$2.27-$3.81-$3.81N/A
    Fiscal year ending Dec 31, 2027-$1.45-$1.45-$1.40-$1.34-$1.34N/A

    Frequently Asked Questions About ARMP

    What is the ARMP stock forecast?

    Consensus analyst estimates put Armata Pharmaceuticals's EPS at -$1.87 for the fiscal year ending Dec 31, 2026, on revenue of $4.25M.

    What EPS do analysts expect from ARMP next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$1.87, with estimates from -$2.27 to -$1.46 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$1.45, with estimates from -$2.04 to -$0.85 from 2 analysts.

    What revenue do analysts expect from Armata Pharmaceuticals next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $4.25M, with estimates from $3.30M to $5.20M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $2.75M.

    How many analysts cover ARMP?

    2 analysts estimate EPS for Armata Pharmaceuticals for the fiscal year ending Dec 31, 2026.